(Malou) MCP Kuppen MSc

All publications (4)

• Article (4)

  • M.C.P. Kuppen, H.M. Westgeest, A.J.M. Van den Eertwegh, J. Coenen, R.J.A. van Moorselaar, P. Berg, M.M. Geenen, N. Mehra, M.P. Hendriks, M.I. Lampe, A.C.M. van de Luijtgaarden, F.P.J. Peters, T.A. Roeleveld, T. Smilde, R. de Wit, I. van Oort, W. Gerritsen & C.A. de Groot (2020). Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands. Clinical Genitourinary Cancer, 18 (3), E233-E253. doi: 10.1016/j.clgc.2019.11.015
  • M.C.P. Kuppen & H.M. Westgeest (2019). Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry. European Urology Oncology. doi: 10.1016/j.euo.2019.09.005.
  • H.M. Westgeest, M.C.P. Kuppen, A.J.M. Van den Eertwegh, R. de Wit, J. Coenen, H. van den Berg, N. Mehra, I. van Oort, L. Fossion, M.P. Hendriks, H. Bloemendal, A.C.M. van de Luijtgaarden, D. Huinink, A.C.M. van den Bergh, J.G. Bosch, M.B. Polee, N. Weijl, A. Bergman, C.A. de Groot & W. Gerritsen (2019). Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands. Clinical Genitourinary Cancer, 17 (5), E946-E956. doi: 10.1016/j.clgc.2019.05.018
  • M.C.P. Kuppen & H.M. Westgeest (2019). Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands. Clinical Genitourinary Cancer. doi: 10.1016/j.clgc.2019.11.015.

Teaching (1)

Present position